Overview
Lise Mangiante practices practicing medicine in Lyon, France.
Ms. Mangiante is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Mesothelioma, Lung Cancer, and Retinoblastoma.
She is actively involved in clinical research, co-authoring 18 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lise Mangiante
Is Lise Mangiante a top-rated expert for Neuroendocrine Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Lise Mangiante is classified as an Advanced expert for Neuroendocrine Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lise Mangiante participate in research or clinical trials?
Yes. Lise Mangiante has published 18 articles and abstracts on conditions like Neuroendocrine Tumor. You can view a list of Lise Mangiante's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Neuroendocrine TumorMs. Mangiante isAdvanced. Learn about Neuroendocrine Tumor.
- Experienced
- Lung CancerMs. Mangiante isExperienced. Learn about Lung Cancer.
- MesotheliomaMs. Mangiante isExperienced. Learn about Mesothelioma.
- RetinoblastomaMs. Mangiante isExperienced. Learn about Retinoblastoma.
- Triple-Negative Breast CancerMs. Mangiante isExperienced. Learn about Triple-Negative Breast Cancer.